Is Daito Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Daito Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 28th of November 2024 were paid JPY0 per share. Over the last 26 times between 2010 and 2024, Daito Pharmaceutical has paid JPY456.45454 with an average of JPY17.56 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Daito Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY2 612.72, you would have made a loss of JPY-300.72 per share or -11.51%
Yes, the average daily trading liquidity for Daito Pharmaceutical is JPY52 969 thousand. You should therefore be able to get in and out of your positions relatively fast.
Daito Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.74, the company's ability to pay off the debt is good. Daito Pharmaceutical has a good net profit margin of 7.26% and should have high tolerances against inflation.
We have calculated the inflation risk for Daito Pharmaceutical to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.